EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer

Abstract

With ageing of the population, both the risks of cardiovascular disease (CVD) and cancer are increasing worldwide, and the risk factors (e.g. obesity, diabetes) are often shared between the two conditions. Thus, more subjects will also develop the two illnesses concurrently [...].